Lonza Group AG stock under pressure amid Swiss trade surplus data and CDMO transformation momentum

FierceBiotechUCB inks $2B Candid buyout to join Gilead in autoimmune field

IlluminaIllumina Partners with Florida State University Lab for Rare Disease Genome Sequencing - Clinical Lab Products

BioPharma DiveUCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases

BioPharma DiveWhat is your AI drug repurposing strategy missing?

FierceBiotech‘Real momentum’ or ‘completely absurd’? How Trump’s support has shaken up psychedelics

Cytiva (Google News)Rockwell Automation and Cytiva join hands to accelerate digital transformation for biopharma companies - BioSpectrum Asia

Cytiva (Google News)Rockwell Automation and Cytiva Introduce Figurate SCADA: Addressing Digital Fragmentation in Biopharma Manufacturing - ARCweb.com

Lonza NewsAntibody Drug Conjugates Contract Market: North America Leads; - openPR.com

FierceBiotechScaling theranostics through access, safety and trust

Endpoints NewsUCB bets $2 billion on Candid's T cell engager ambitions

IlluminaWilkins Investment Counsel Inc. Trims Stake in Illumina, Inc. $ILMN - MarketBeat

Samsung Biologics(LEAD) Samsung Biologics labor union set to resume talks with management on Monday - Yonhap News Agency